Are Cancer Stem Cells a Suitable Target for Breast Cancer Immunotherapy?
There is substantial evidence to suggest that complete tumor eradication relies on the effective elimination of cancer stem cells (CSCs). CSCs have been widely described as mediators of resistance to conventional therapies, including chemo- and radiotherapy, as well as of tumor metastasization and r...
Main Authors: | Roberto Ruiu, Antonino Di Lorenzo, Federica Cavallo, Laura Conti |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-04-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.877384/full |
Similar Items
-
The Evolution of Cancer Immunotherapy
by: Meshaal Khan, et al.
Published: (2021-06-01) -
Current Advancements and Future Perspectives of Immunotherapy in Breast Cancer Treatment
by: Maria Vasileiou, et al.
Published: (2023-05-01) -
Emerging Immunotherapies against Novel Molecular Targets in Breast Cancer
by: Vignesh Sivaganesh, et al.
Published: (2021-02-01) -
Editorial: Engineered Targeted Cancer Immunotherapies
by: Massimo Fantini, et al.
Published: (2022-07-01) -
Non‐coding RNAs in cancer immunotherapy: Predictive biomarkers and targets
by: Murad Alahdal, et al.
Published: (2023-09-01)